Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$62.12 - $84.15 $2.86 Million - $3.88 Million
46,074 Added 305.96%
61,133 $4.38 Million
Q1 2024

May 10, 2024

BUY
$65.98 - $77.09 $993,592 - $1.16 Million
15,059 New
15,059 $1.06 Million
Q3 2023

Nov 08, 2023

BUY
$67.52 - $89.42 $457,245 - $605,552
6,772 Added 142.75%
11,516 $783,000
Q2 2023

Aug 11, 2023

SELL
$73.76 - $85.98 $316,209 - $368,596
-4,287 Reduced 47.47%
4,744 $387,000
Q1 2023

May 11, 2023

SELL
$71.62 - $86.62 $153,911 - $186,146
-2,149 Reduced 19.22%
9,031 $670,000
Q4 2022

Feb 14, 2023

BUY
$80.67 - $352.29 $502,090 - $2.19 Million
6,224 Added 125.59%
11,180 $926,000
Q3 2022

Nov 14, 2022

BUY
$282.54 - $391.85 $791,394 - $1.1 Million
2,801 Added 129.98%
4,956 $1.41 Million
Q2 2022

Aug 09, 2022

BUY
$322.67 - $449.65 $695,353 - $968,995
2,155 New
2,155 $747,000
Q1 2022

May 09, 2022

SELL
$353.85 - $487.79 $240,971 - $332,184
-681 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$456.15 - $525.06 $182,460 - $210,023
-400 Reduced 37.0%
681 $352,000
Q3 2021

Nov 10, 2021

BUY
$444.87 - $538.88 $133,461 - $161,664
300 Added 38.41%
1,081 $524,000
Q2 2021

Aug 11, 2021

BUY
$387.35 - $450.26 $302,520 - $351,653
781 New
781 $352,000
Q4 2020

Feb 09, 2021

SELL
$246.9 - $321.87 $291,588 - $380,128
-1,181 Closed
0 $0
Q3 2020

Oct 15, 2020

BUY
$232.22 - $282.96 $274,251 - $334,175
1,181 New
1,181 $293,000
Q1 2020

Apr 29, 2020

SELL
$161.17 - $221.51 $412,434 - $566,844
-2,559 Closed
0 $0
Q4 2019

Jan 23, 2020

BUY
$189.68 - $222.09 $485,391 - $568,328
2,559 New
2,559 $562,000
Q3 2019

Oct 16, 2019

SELL
$183.56 - $216.72 $197,877 - $233,624
-1,078 Closed
0 $0
Q2 2019

Jul 10, 2019

BUY
$188.72 - $215.43 $203,440 - $232,233
1,078 New
1,078 $225,000
Q1 2019

May 10, 2019

SELL
$136.09 - $200.44 $254,216 - $374,421
-1,868 Closed
0 $0
Q4 2018

Feb 08, 2019

BUY
$132.75 - $203.8 $247,977 - $380,698
1,868 New
1,868 $299,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.6B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.